|
Gender (female vs. male)
|
0.993 (0655–1.506)
|
P = 0.974
| | |
|
Age (per year increase)
| | | | |
|
Creatinine (per µmol/L increase)
|
1.003 (1.002–1.004)
|
P = 0.001
|
1.007 (1.004–1.010)
|
P < 0.001
|
|
Respiratory disease ( yes vs. no )
|
2.049 (1.335–3.146)
|
P = 0.001
|
1.872 (1.170–3.000)
|
P = 0.009
|
|
Dialysis (yes vs. no )
|
4.103 (1.809–9.306)
|
P < 0.001
|
30.24 (2.549–358.7)
|
P = 0.007
|
|
Smoking (yes vs. no)
|
0.937 (0.637–1.378)
|
P = 0.741
| | |
|
BMI (per kg/m2 increase)
|
0.956 (0.922–0.991)
|
P = 0.019
|
0.950 (0.914–0.987)
|
P = 0.008
|
|
TBSA (per m2 increase)
|
0.706 (0.304–1.637)
|
P = 0.417
| | |
|
NYHA class 4
|
1.194 (0.780–1.829)
|
P = 0.872
| | |
|
Preoperative Hb (per g/L increase)
|
0.967 (0.957–0.976)
|
P < 0.001
|
0.971 (0.961–0.982)
|
P < 0.001
|
|
Antiplatelet use < 24 h ( yes vs. no )
|
1.063 (0.504–2.246)
|
P = 0.872
| | |
|
Anticoagulant use < 24 h ( yes vs. no )
|
1.194 (0.780–1.829)
|
P = 0.414
| | |
|
Non valve/CABG ( yes vs. no )
|
1.259 (0.754–2.102)
|
P = 0.378
| | |
|
Previous cardiothoracic intervention ( yes vs. no )
|
2.877 (1.934–4.281)
|
P < 0.001
|
2.578 (1.681–3.953)
|
P < 0.001
|
|
Presence of cardiogenic shock preoperatively (yes vs. no)
|
7.260 (4.480–11.77)
|
P < 0.001
|
6.329 (3.788–10.53)
|
P < 0.001
|
